Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 6/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | SCN4A | P35499 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.40 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28301379 | 0.85 | IDO1 (0.44) | CNR2NOTUMIDO1 | |
| SCHEMBL20472405 | 0.79 | CNR2 (0.47) | CNR2NOTUMIDO1CNR1P2RX7 | |
| SCHEMBL16731967 | 0.78 | ALDH1A1 (0.32) | BLM | |
| SCHEMBL4446563 | 0.75 | ALPL (0.30) | — | |
| SCHEMBL6017122 | 0.73 | ALDH1A1 (0.52) | IDO1 | |
| SCHEMBL5084514 | 0.73 | CNR2 (0.57) | CNR2NOTUMIDO1CNR1P2RX7 | |
| SCHEMBL2985787 | 0.73 | — | — | |
| SCHEMBL14051355 | 0.71 | CNR2 (0.52) | CNR2NOTUMIDO1CNR1P2RX7 | |
| SCHEMBL27599028 | 0.70 | IDO1 (0.46) | CNR2NOTUMIDO1CNR1P2RX7 | |
| SCHEMBL1534219 | 0.70 | HPGD (0.39) | IDO1CYP2D6MAOAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60260503-A | — | — | None | — | — | JP | disclosed |
| US-9761811-B2 | Organic electroluminescence element and material for organic electroluminescence element | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| EP-2869356-B1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2016-10-12 | — | — | EP | disclosed |
| US-20150249217-A1 | TRIAZINE-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-09-03 | — | — | US | disclosed |
| US-20150188056-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2015-07-02 | — | — | US | disclosed |
| EP-2869356-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2015-05-06 | — | — | EP | disclosed |
| CN-102791659-A | Material for electronic devices | MERCK PATENT GMBH | 2012-11-21 | — | — | CN | disclosed |
| US-20120217449-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-08-30 | — | — | US | disclosed |
| US-20110306080-A1 | DETERMINATION OF LAMOTRIGINE BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2011-12-15 | — | — | US | disclosed |
| JP-S60260503-A | METHOD OF REDUCING CHEMICAL INJURY OF HERBICIDE AND COMPOSITION THEREFOR | NISSAN CHEM IND LTD | 1985-12-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150249217-A1 | TRIAZINE-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | IKZF2, POU5F1, ETV6 | CNR2 3274/4885NOTUM 2671/4885IDO1 1876/4885 |
| US-20120217449-A1 | MATERIALS FOR ELECTRONIC DEVICES | EFNA1, DDT, ERCC1 | CNR2 4430/4885NOTUM 2950/4885IDO1 2349/4885 |
| US-20150188056-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | LEF1, EPB41, ARL1 | CNR2 3716/4885NOTUM 4235/4885IDO1 2398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.